- Estrogen-receptor and progesterone-receptor expression both <10% by immunohistochemistry (IHC) and HER2 negative by IHC or non-amplified as determined by the current ASCO-CAP criteria. If patient has more than one histological result, the most recent one has to be considered for inclusion.